This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
proper | frequency |
---|---|
BCG | 2892 |
COVID-19 | 698 |
SARS | 614 |
CoV-2 | 453 |
T | 340 |
M. | 273 |
Calmette | 249 |
Mycobacterium | 223 |
Salmonella | 156 |
Guérin | 145 |
TB | 137 |
HIV | 130 |
DC | 130 |
MKP-1 | 129 |
CD4 | 129 |
LPS | 124 |
CD8 | 124 |
Lf | 124 |
PID | 119 |
Health | 115 |
Fig | 114 |
China | 110 |
Bacillus | 109 |
PD | 102 |
Africa | 102 |
CVID | 99 |
World | 98 |
L1 | 98 |
Guerin | 96 |
B | 96 |
IL-6 | 94 |
CoV | 94 |
Bacille | 91 |
Table | 86 |
A | 84 |
SDR | 80 |
C | 79 |
TNF | 78 |
CC | 78 |
India | 76 |
April | 76 |
BY | 74 |
University | 70 |
ND | 67 |
SCID | 65 |
HIV-1 | 65 |
Coronavirus | 65 |
SIGN | 61 |
RNA | 60 |
PEP | 59 |
IgM | 58 |
NK | 57 |
IgG | 56 |
Vaccine | 55 |
Vaccination | 55 |
mg | 54 |
medRxiv | 54 |
Sweden | 53 |
MAPK | 53 |
IgA | 52 |
IVIG | 52 |
DPM | 52 |
Organization | 51 |
UK | 51 |
May | 50 |
South | 50 |
sha | 49 |
HLA | 49 |
CGD | 49 |
USA | 48 |
S | 48 |
Lactoferrin | 48 |
IFN | 48 |
HSCT | 48 |
leprae | 47 |
Listeria | 47 |
DOI | 46 |
Covid-19 | 45 |
Italy | 45 |
M | 43 |
chemoprophylaxis | 43 |
PCR | 42 |
NC | 42 |
Mtb | 42 |
S. | 41 |
Disease | 41 |
United | 40 |
June | 40 |
J | 40 |
Group | 40 |
Germany | 40 |
II | 39 |
E. | 39 |
Human | 39 |
STAT3 | 39 |
States | 39 |
α | 38 |
Wuhan | 38 |
Immunity | 38 |
East | 37 |
CFR | 37 |
MERS | 36 |
C. | 36 |
Brazil | 36 |
AIDS | 36 |
ACE2 | 36 |
Lm | 36 |
Research | 35 |
March | 35 |
Clinical | 35 |
IL-10 | 34 |
siRNA | 34 |
phoP | 33 |
lactoferrin | 33 |
New | 33 |
Hospital | 33 |
tb | 32 |
serovar | 32 |
Prevention | 32 |
CI | 32 |
Trained | 31 |
RD | 31 |
Immunology | 31 |
Department | 31 |
Center | 31 |
BCGosis | 30 |
TMPRSS2 | 30 |
KD | 30 |
Medical | 29 |
Japan | 29 |
Institute | 29 |
Influenza | 29 |
Global | 29 |
bLf | 29 |
Russia | 27 |
HBV | 27 |
MHC | 27 |
Middle | 27 |
Leprosy | 27 |
SIGNR | 27 |
dl | 27 |
enterica | 27 |
mycobacterial | 27 |
nan | 26 |
National | 26 |
International | 26 |
IgE | 26 |
Helicobacter | 26 |
DNA | 26 |
γ | 25 |
WHO | 25 |
PhoP | 25 |
ASIA | 25 |
FC | 24 |
Europe | 24 |
H1N1 | 24 |
IV | 24 |
PPD | 24 |
L. | 23 |
Kawasaki | 23 |
Figure | 23 |
Escherichia | 23 |
Atlas | 22 |
Guinea | 22 |
Data | 22 |
Pasteur | 22 |
TCA | 22 |
TLR4 | 22 |
meta | 22 |
Netherlands | 21 |
Association | 21 |
Australia | 21 |
ERK1/2 | 21 |
European | 21 |
hepatitis | 21 |
RT | 21 |
Shigella | 21 |
Spain | 21 |
pH | 21 |
Children | 20 |
July | 20 |
CD19 | 20 |
Bissau | 20 |
HPV | 20 |
CGS | 20 |
LABV | 20 |
Tice | 20 |
Tuberculosis | 20 |
lymphopenia | 20 |
mRNA | 20 |
SDS | 20 |
Immune | 19 |
Aldrich | 19 |
Birkhaug | 19 |
Candida | 19 |
Centre | 19 |
Control | 19 |
Cov-2 | 19 |
Development | 19 |
DnaK | 19 |
France | 19 |
MSMD | 19 |
Immunization | 19 |
MVA | 19 |
Protection | 19 |
Study | 19 |
Treatment | 19 |
Turkey | 19 |
UBIP | 19 |
mL | 19 |
sars | 19 |
• | 19 |
ADE | 18 |
AR | 18 |
COLEP | 18 |
M1 | 18 |
MDP | 18 |
Novel | 18 |
ST | 18 |
doi | 18 |
typhimurium | 18 |
Review | 18 |
Iran | 17 |
COVID | 17 |
CPM | 17 |
ClinicalTrials.gov | 17 |
D | 17 |
DU | 17 |
I | 17 |
ITP | 17 |
Immunol | 17 |
Immunodeficiency | 17 |
JNK | 17 |
Mucosal | 17 |
Respiratory | 17 |
Syndrome | 17 |
TLR2 | 17 |
US | 17 |
West | 17 |
vivo | 17 |
MMR | 17 |
Indians | 16 |
LPEP | 16 |
Infection | 16 |
Induction | 16 |
OXPHOS | 16 |
Diseases | 16 |
CMap | 16 |
CD3 | 16 |
Mycobacterial | 16 |
LTBI | 16 |
PAGE | 16 |
parvum | 16 |
SPM | 16 |
Safety | 16 |
Science | 16 |
TLR | 16 |
XLA | 16 |
lprG | 16 |
monocyte | 16 |
PD-1 | 16 |
Ebola | 15 |
Kong | 15 |
January | 15 |
Indonesia | 15 |
Effect | 15 |
Analysis | 15 |
Denmark | 15 |
Cpn60.1 | 15 |
Canada | 15 |
BALB | 15 |
MS | 15 |
L | 15 |
B. | 15 |
OS | 15 |
SP | 15 |
van | 15 |
Vaccines | 15 |
Th1 | 15 |
September | 15 |
Virus | 15 |
Report | 15 |
Project | 15 |
PBS | 15 |
P. | 15 |
Omenn | 15 |
Mycobacteria | 14 |
ADEM | 14 |
Bank | 14 |
CT | 14 |
Cancer | 14 |
DCs | 14 |
GAPDH | 14 |
HIES | 14 |
ICU | 14 |
IRIS | 14 |
Norway | 14 |
PNP | 14 |
RC | 14 |
SIV | 14 |
TLR3 | 14 |
York | 14 |
bacille | 14 |
heterologous | 14 |
mTOR | 14 |
Pediatric | 14 |
G | 13 |
N | 13 |
Mexico | 13 |
Ig | 13 |
IL-1 | 13 |
ARDS | 13 |
FDA | 13 |
CVD | 13 |
Ankara | 13 |
Nature | 13 |
NW | 13 |
Rd | 13 |
Primary | 13 |
SLE | 13 |
R | 13 |
monocytogenes | 13 |
mM | 13 |
Sigma | 13 |
kDa | 13 |
SC | 13 |
S1 | 13 |
phox | 13 |
R100 | 13 |
Corynebacterium | 12 |
HSP | 12 |
E | 12 |
Drug | 12 |
Database | 12 |
DR | 12 |
CMC | 12 |
Committee | 12 |
City | 12 |
Chemoprophylaxis | 12 |
CTL | 12 |
IC31 | 12 |
August | 12 |
ADT | 12 |
Hydroxychloroquine | 12 |
Front | 12 |
IQR | 12 |
Prague | 12 |
Immunogenicity | 12 |
preprint | 12 |
Typhi | 12 |
TM | 12 |
RCT | 12 |
Pseudomonas | 12 |
Sars | 12 |
PSA | 12 |
PA | 12 |
NOD2 | 12 |
Malaysia | 12 |
Lactococcus | 12 |
KO | 12 |
Crohn | 11 |
Netea | 11 |
Innate | 11 |
IL-2 | 11 |
IL-12 | 11 |
Hepes | 11 |
Efficacy | 11 |
Effectiveness | 11 |
BC | 11 |
Cov | 11 |
Correlation | 11 |
ChAdOx1 | 11 |
Care | 11 |
CD38 | 11 |
Belgium | 11 |
American | 11 |
Molecular | 11 |
Lombardy | 11 |
NimbleGen | 11 |
TLRs | 11 |
Portugal | 11 |
| | 11 |
hsa | 11 |
calmette | 11 |
apo | 11 |
Typhimurium | 11 |
Trial | 11 |
st | 11 |
Streptococcus | 11 |
Recombinant | 11 |
RA | 11 |
Public | 11 |
Protein | 11 |
Propionibacterium | 11 |
Society | 11 |
Di | 10 |
Med | 10 |
KIR | 10 |
IL-1β | 10 |
George | 10 |
Gaussian | 10 |
CD40 | 10 |
December | 10 |
Cytokines | 10 |
Clin | 10 |
ATP | 10 |
< | 10 |
Pandemic | 10 |
Moreau | 10 |
Lancet | 10 |
Population | 10 |
WASP | 10 |
Rates | 10 |
κB | 10 |
mass | 10 |
histolytica | 10 |
hLf | 10 |
der | 10 |
immunoprophylaxis | 10 |
U | 10 |
Ty21a | 10 |
Tobit | 10 |
State | 10 |
Staphylococcus | 10 |
Evaluation | 9 |
Intravesical | 9 |
Infectious | 9 |
IGSC | 9 |
Korea | 9 |
Heterologous | 9 |
Healthcare | 9 |
HIGM | 9 |
Gulf | 9 |
Foundation | 9 |
CN | 9 |
DUSP2 | 9 |
DM | 9 |
DGS | 9 |
Class | 9 |
Cell | 9 |
BCGitis | 9 |
Antigen | 9 |
Adults | 9 |
APS | 9 |
M2 | 9 |
Ltd. | 9 |
N. | 9 |
MRs | 9 |
Systems | 9 |
Malaria | 9 |
≥ | 9 |
ml | 9 |
Workers | 9 |
Wang | 9 |
Toll | 9 |
Taiwan | 9 |
TURBT | 9 |
TAFA | 9 |
± | 9 |
Sepharose | 9 |
NOD2-dependent | 9 |
SHIV | 9 |
Microbiology | 9 |
NAC | 9 |
Miller | 9 |
Randomized | 9 |
Regional | 9 |
Remdesivir | 9 |
SCIG | 9 |
Gene | 8 |
H. | 8 |
HR | 8 |
Hopkins | 8 |
I. | 8 |
III | 8 |
IL-17A | 8 |
Identification | 8 |
Laboratory | 8 |
Inc. | 8 |
Indian | 8 |
Kingdom | 8 |
Leishmania | 8 |
LepVax | 8 |
Lopinavir | 8 |
MDT | 8 |
F | 8 |
GOF | 8 |
Bruton | 8 |
ESX-5 | 8 |
BSA | 8 |
MTB | 8 |
AA | 8 |
Ag85 | 8 |
Anti | 8 |
Antibody | 8 |
Asia | 8 |
BP | 8 |
CNS | 8 |
ESID | 8 |
COVID‐19 | 8 |
CRS | 8 |
CYBB | 8 |
CpG | 8 |
Dis | 8 |
Dr. | 8 |
ELISA | 8 |
MIH5 | 8 |
G. | 8 |
Medicine | 8 |
Springer | 8 |
T. | 8 |
TNFα | 8 |
V. | 8 |
War | 8 |
Wave | 8 |
Yersinia | 8 |
administration | 8 |
bp | 8 |
disease | 8 |
gp120 | 8 |
hyper | 8 |
hypogammaglobulinemia | 8 |
itaconate | 8 |
lactis | 8 |
lg | 8 |
mevalonate | 8 |
Meta | 8 |
Stata | 8 |
glucan | 8 |
remdesivir | 8 |
Pediatrics | 8 |
Spearman | 8 |
Micronesia | 8 |
Mortality | 8 |
Mw | 8 |
NADPH | 8 |
PI | 8 |
Pediatr | 8 |
NBS | 8 |
RCTs | 8 |
Risk | 8 |
S4 | 8 |
SAP | 8 |
Sanger | 8 |
School | 8 |
Province | 8 |
Scientific | 8 |
Guidelines | 7 |
Hepatitis | 7 |
IL-4 | 7 |
IIM | 7 |
Hungary | 7 |
H37Rv | 7 |
Henoch | 7 |
HCoV | 7 |
H3K4 | 7 |
IPEX | 7 |
IL-8 | 7 |
Mann | 7 |
Immodulon | 7 |
Initiative | 7 |
Invitrogen | 7 |
LF82 | 7 |
LFchimera | 7 |
LLO | 7 |
MOI | 7 |
MTBVAC | 7 |
Measles | 7 |
GDP | 7 |
GFP | 7 |
America | 7 |
Freund | 7 |
CORONA | 7 |
Agency | 7 |
Allergy | 7 |
Alzheimer | 7 |
Model | 7 |
BADAS | 7 |
BAL | 7 |
Barr | 7 |
CD | 7 |
CFA | 7 |
Chloroquine | 7 |
FMS | 7 |
College | 7 |
Commons | 7 |
Comparative | 7 |
Creative | 7 |
Cross | 7 |
Division | 7 |
Entamoeba | 7 |
Epstein | 7 |
Extension | 7 |
Mechanisms | 7 |
IgD | 7 |
NKT | 7 |
TCR | 7 |
Technology | 7 |
Th17 | 7 |
Th2 | 7 |
Therapeutics | 7 |
Trials | 7 |
Type | 7 |
VPM1002 | 7 |
Vazquez | 7 |
Y | 7 |
Young | 7 |
Zheng | 7 |
association | 7 |
azithromycin | 7 |
dipeptide | 7 |
favipiravir | 7 |
guerin | 7 |
https://doi.org/10.1101/2020.05.01.20087437 | 7 |
muramyl | 7 |
national | 7 |
tocilizumab | 7 |
NMIBC | 7 |
TT | 7 |
antigen | 7 |
Switzerland | 7 |
PhoR | 7 |
Neonatal | 7 |
Supplementary | 7 |
Network | 7 |
October | 7 |
PCa | 7 |
PMN | 7 |
PRRs | 7 |
PV | 7 |
Phase | 7 |
PPE | 7 |
Platform | 7 |
Poland | 7 |
R. | 7 |
RBD | 7 |
Republic | 7 |
S2 | 7 |
STK4 | 7 |
San | 7 |
Sciences | 7 |
Slovakia | 7 |
Gleason | 6 |
Hubei | 6 |
Hadassah | 6 |
HAE | 6 |
H7N9 | 6 |
H | 6 |
Federated | 6 |
Glaxo | 6 |
GABRIEL | 6 |
Expression | 6 |
February | 6 |
IGIV | 6 |
Faculty | 6 |
IGHy | 6 |
Maria | 6 |
Immunodeficiencies | 6 |
Interaction | 6 |
Ireland | 6 |
J. | 6 |
K. | 6 |
K695R | 6 |
LprG | 6 |
MFS | 6 |
MMF | 6 |
Mers | 6 |
Mice | 6 |
Mincle | 6 |
Ministry | 6 |
ESAT-6 | 6 |
Egypt | 6 |
Acr | 6 |
ERG | 6 |
CD14 | 6 |
NBT | 6 |
-Japan | 6 |
/l | 6 |
A. | 6 |
AIEC | 6 |
AM | 6 |
AS | 6 |
Adjuvant | 6 |
Autoimmune | 6 |
BMI | 6 |
Bekkering | 6 |
Biological | 6 |
Box | 6 |
CD27 | 6 |
EDTA | 6 |
CFU | 6 |
CI95 | 6 |
CLV | 6 |
COPD | 6 |
Central | 6 |
Chaisemartin | 6 |
Countries | 6 |
Covid | 6 |
Curtis | 6 |
Da | 6 |
Diagnosis | 6 |
EAU | 6 |
EBV | 6 |
NADH | 6 |
Thailand | 6 |
NTM | 6 |
Vibrio | 6 |
W | 6 |
W. | 6 |
Weng | 6 |
Whitney | 6 |
Wilcoxon | 6 |
Worldometers | 6 |
X | 6 |
Zero | 6 |
antiphospholipid | 6 |
asd | 6 |
dectin-1 | 6 |
den | 6 |
doc_id | 6 |
east | 6 |
gamma | 6 |
glyceraldehyde-3-phosphate | 6 |
herpes | 6 |
https://doi.org/10.1101/2020.05.20.20107755 | 6 |
https://doi.org/10.1101/2020.09.06.20189423 | 6 |
hydroxychloroquine | 6 |
kg | 6 |
metformin | 6 |
miRNAs | 6 |
mo | 6 |
pemphigoid | 6 |
urology | 6 |
μg | 6 |
NYVAC | 6 |
№ | 6 |
Viral | 6 |
guérin | 6 |
Union | 6 |
Q4 | 6 |
OC43 | 6 |
OX40 | 6 |
Uganda | 6 |
Oxford | 6 |
P | 6 |
PIDs | 6 |
PM | 6 |
PPP | 6 |
Paris | 6 |
Patient | 6 |
Professor | 6 |
PubMed | 6 |
Q2 | 6 |
PMR | 6 |
QPCR | 6 |
Schnitzler | 6 |
UTUC | 6 |
Summary | 6 |
Structure | 6 |
UIP | 6 |
Schönlein | 6 |
Stattic | 6 |
S3 | 6 |
Robust | 6 |
Rio | 6 |
Registry | 6 |
RPM | 6 |
Finland | 5 |
FAO | 5 |
F. | 5 |
Expert | 5 |
Estonia | 5 |
Epidemiology | 5 |
Enhanced | 5 |
Emergency | 5 |
ESR | 5 |
Education | 5 |
Eastern | 5 |
DU1 | 5 |
ESX-1 | 5 |
David | 5 |
Dr | 5 |
Detection | 5 |
Delhi | 5 |
GVHD | 5 |
Food | 5 |
Humoral | 5 |
Giardia | 5 |
Humans | 5 |
IMM-101 | 5 |
DQB1 | 5 |
IL6 | 5 |
IL12 | 5 |
IL-18 | 5 |
IL-12Rb1 | 5 |
IG | 5 |
Host | 5 |
Government | 5 |
Herpes | 5 |
Hematopoietic | 5 |
Healthy | 5 |
HFI | 5 |
HCV | 5 |
HA | 5 |
Greece | 5 |
DRB1 | 5 |
Alaska | 5 |
Cytoscape | 5 |
African | 5 |
Bangladesh | 5 |
BRACE | 5 |
BCGinduced | 5 |
Arbidol | 5 |
Approach | 5 |
Appendix | 5 |
Analytics | 5 |
APC | 5 |
Bladder | 5 |
ALVAC | 5 |
ALPS | 5 |
ALI | 5 |
AC | 5 |
8) | 5 |
-Moreau | 5 |
IS6110 | 5 |
Beijing | 5 |
Bordetella | 5 |
Combination | 5 |
Cape | 5 |
Coley | 5 |
CoA | 5 |
Clinic | 5 |
Chronic | 5 |
Chen | 5 |
Characteristics | 5 |
Chan | 5 |
COV-2 | 5 |
Brodin | 5 |
CFS | 5 |
CF | 5 |
CD86 | 5 |
CD25 | 5 |
CBC | 5 |
C3H | 5 |
C.laurentii | 5 |
IRG1 | 5 |
flagellin | 5 |
IU | 5 |
Ritonavir | 5 |
Wiskott | 5 |
WhiB3 | 5 |
Urology | 5 |
UNICEF | 5 |
UCTD | 5 |
Tuftsin | 5 |
Tallinn | 5 |
TZ | 5 |
System | 5 |
Statistical | 5 |
Social | 5 |
Set7 | 5 |
Schoen | 5 |
Schistosoma | 5 |
Saharan | 5 |
SNPs | 5 |
SDH | 5 |
Zhang | 5 |
aplasia | 5 |
atlas | 5 |
sera | 5 |
IgG1 | 5 |
β | 5 |
www.nature.com/scientificreports/ | 5 |
www.nature.com/nrmicro | 5 |
vaccine | 5 |
tuftsin | 5 |
simplex | 5 |
phosphatase-1 | 5 |
bovis | 5 |
mm | 5 |
listeriolysin | 5 |
https://doi.org/10.1101/2020.05.13.20100156 | 5 |
histone | 5 |
hepatosplenomegaly | 5 |
enterotoxigenic | 5 |
covid-19 | 5 |
Robert | 5 |
ritonavir | 5 |
Rep | 5 |
Kamat | 5 |
MSgp7 | 5 |
MLPA | 5 |
MCV1 | 5 |
MAPKs | 5 |
London | 5 |
LAM | 5 |
Kenya | 5 |
Johns | 5 |
MenB | 5 |
Itaconate | 5 |
Island | 5 |
Information | 5 |
Infections | 5 |
Induced | 5 |
RG | 5 |
Immunometabolic | 5 |
Management | 5 |
Institut | 5 |
NCT04327206 | 5 |
Observatory | 5 |
NCT04328441 | 5 |
RFS | 5 |
Q1 | 5 |
Program | 5 |
Plovdiv | 5 |
Plasmodium | 5 |
Peyer | 5 |
Protective | 5 |
RCC | 5 |
NL63 | 5 |
Nmax | 5 |
Nigeria | 5 |
Nepal | 5 |
Natural | 5 |
NSP3 | 5 |
Note | 5 |
Gupta | 4 |
H37Ra | 4 |
H3K4me1 | 4 |
H5N1 | 4 |
HDL | 4 |
HIDS | 4 |
Hill | 4 |
HKU1 | 4 |
HSV2 | 4 |
HeCr | 4 |
Heijden | 4 |
Growth | 4 |
Hickey | 4 |
Hansen | 4 |
GLA | 4 |
4 | |
Geneva | 4 |
General | 4 |
Geijtenbeek | 4 |
Gag | 4 |
GWS | 4 |
GMP | 4 |
GE | 4 |
GBS | 4 |
Freiburg | 4 |
Freedom | 4 |
FoxP3 | 4 |
Forbes | 4 |
Hong | 4 |
Folkhälsomyndigheten | 4 |
HlyA | 4 |
KDM5 | 4 |
Hospitals | 4 |
IBD | 4 |
Factors | 4 |
Lysate | 4 |
Lymphopenia | 4 |
Ln(Y | 4 |
Lin | 4 |
License | 4 |
Liang | 4 |
Lfcins | 4 |
Lee | 4 |
LSDV | 4 |
L2 | 4 |
Kumar | 4 |
Kiribati | 4 |
Kazakhstan | 4 |
John | 4 |
Japanese | 4 |
Janeiro | 4 |
JL | 4 |
JHU | 4 |
Intradermal | 4 |
Interference | 4 |
Inhibitor | 4 |
Index | 4 |
Immunoglobulin | 4 |
IL2RG | 4 |
IL-22 | 4 |
IL-13 | 4 |
IL-11 | 4 |
IFNgR1 | 4 |
Federation | 4 |
CD11b | 4 |
Factor | 4 |
FWHM | 4 |
CD80 | 4 |
CD8+CD38+HLA | 4 |
CD28 | 4 |
CD21 | 4 |
CA | 4 |
C1 | 4 |
Buffer | 4 |
Bradford | 4 |
Biswas | 4 |
Biotech | 4 |
Biolegend | 4 |
Berlin | 4 |
Becton | 4 |
Banerjee | 4 |
BMT | 4 |
Application | 4 |
Anne | 4 |
Andrew | 4 |
Age | 4 |
Adult | 4 |
Absenteeism | 4 |
AT | 4 |
AG | 4 |
AEs | 4 |
A3 | 4 |
2b | 4 |
0,05 | 4 |
-Glaxo | 4 |
MBC | 4 |
CER | 4 |
CSS | 4 |
CT6 | 4 |
D10 | 4 |
Enhancement | 4 |
England | 4 |
Economics | 4 |
EURO | 4 |
ESX | 4 |
ERK | 4 |
ECE | 4 |
District | 4 |
Dickinson | 4 |
Design | 4 |
Debrecen | 4 |
De | 4 |
Danish | 4 |
Cys | 4 |
Ca | 4 |
Coverage | 4 |
Coparvax | 4 |
Construction | 4 |
Con | 4 |
Computing | 4 |
Cochrane | 4 |
CoVs | 4 |
CoV2 | 4 |
Clarivate | 4 |
Chinese | 4 |
Chile | 4 |
Campylobacter | 4 |
Cambodia | 4 |
MALTALEP | 4 |
Gursel | 4 |
MC | 4 |
alfa | 4 |
Ziff | 4 |
Yekaterinburg | 4 |
YBC | 4 |
Western | 4 |
WBC | 4 |
Vietnam | 4 |
Van | 4 |
Vaccinomics | 4 |
VSD | 4 |
Use | 4 |
Units | 4 |
Ukraine | 4 |
U.S. | 4 |
Treg | 4 |
Transmission | 4 |
Tokyo | 4 |
Time | 4 |
Therapy | 4 |
Tetanus | 4 |
Tanzania | 4 |
Tacket | 4 |
TOF | 4 |
THI | 4 |
Systemic | 4 |
Systematic | 4 |
Susceptibility | 4 |
Statistics | 4 |
St. | 4 |
Smith | 4 |
acnes | 4 |
anti | 4 |
Shoenfeld | 4 |
bacillus | 4 |
MDH2 | 4 |
γC(t | 4 |
ureteroscopy | 4 |
tTG | 4 |
splenocytes | 4 |
rapamycin | 4 |
pranii | 4 |
poxvirus | 4 |
poly | 4 |
p67 | 4 |
p38 | 4 |
novo | 4 |
nd | 4 |
moniliasis | 4 |
mmol | 4 |
menengitis | 4 |
malate | 4 |
lymphadenitis | 4 |
lipoprotein | 4 |
leprosin | 4 |
lactotransferrin | 4 |
key | 4 |
intravesical | 4 |
inflammasome | 4 |
hemolysin | 4 |
enteropathy | 4 |
diff | 4 |
demethylases | 4 |
cenocepacia | 4 |
Slovenia | 4 |
rHuPH20 | 4 |
Severe | 4 |
PPV | 4 |
PHA | 4 |
PGL | 4 |
Outcomes | 4 |
O'Neill | 4 |
O | 4 |
North | 4 |
Nonparametric | 4 |
Nijmegen | 4 |
Neisseria | 4 |
Natives | 4 |
Nations | 4 |
NP | 4 |
NF | 4 |
NAbs | 4 |
NAD | 4 |
N.K. | 4 |
Moliva | 4 |
Milan | 4 |
Mihai | 4 |
MetaCore | 4 |
Merck | 4 |
McSorley | 4 |
Marquesas | 4 |
Majumder | 4 |
Maeda | 4 |
MRI | 4 |
MPL | 4 |
Sci | 4 |
MKP | 4 |
PKR | 4 |
Macrophage | 4 |
PRISMA | 4 |
Practice | 4 |
Scholar | 4 |
PVDF | 4 |
SDHB | 4 |
Rhode | 4 |
Rev | 4 |
Res | 4 |
RPMI | 4 |
RP | 4 |
RM | 4 |
RAG1 | 4 |
Q | 4 |
PspA | 4 |
Providence | 4 |
Richardus | 4 |
Post | 4 |
Pavia | 4 |
Pam | 4 |
Pandemrix | 4 |
≥3 | 4 |
Partnership | 4 |
Pasetti | 4 |
Paulo | 4 |
SE | 4 |
Pham | 4 |
Persian | 4 |
Pearson | 4 |
Peter | 4 |
Policy | 4 |
Placebo | 4 |
Institutes | 3 |
Hypotheses | 3 |
Hyper | 3 |
Horwitz | 3 |
Hoiseth | 3 |
Hib | 3 |
Hodgkin | 3 |
Hispanics | 3 |
Hb | 3 |
Haemophilus | 3 |
HSV | 3 |
HLUHS | 3 |
IC | 3 |
IL-17 | 3 |
IFA | 3 |
IL-5 | 3 |
IL1 | 3 |
IUIS | 3 |
IVC | 3 |
IWV | 3 |
Immunological | 3 |
Immunotherapy | 3 |
Impact | 3 |
Implementation | 3 |
Infants | 3 |
HLH | 3 |
Infolep.org | 3 |
IVS9 | 3 |
Galen | 3 |
HHV-8 | 3 |
G16D | 3 |
Empirical | 3 |
Intervals | 3 |
Engineering | 3 |
English | 3 |
Estimation | 3 |
Exposure | 3 |
FOXP3 | 3 |
Fig.1 | 3 |
Fisher | 3 |
Fixative | 3 |
Forming | 3 |
G1 | 3 |
GEE | 3 |
HCov | 3 |
GGG | 3 |
Genentech | 3 |
Genetic | 3 |
Genetics | 3 |
Genomics | 3 |
Gentschev | 3 |
Gonzalo | 3 |
Good | 3 |
Gross | 3 |
H3 | 3 |
H3K4me3 | 3 |
HCoV-229E | 3 |
Int | 3 |
MD | 3 |
Islands | 3 |
McKendrick | 3 |
MF59 | 3 |
MFI | 3 |
MRC | 3 |
MVA85A | 3 |
Macrophages | 3 |
Malawi | 3 |
Manufacturing | 3 |
Map | 3 |
Marodi | 3 |
Martin | 3 |
Materials | 3 |
Matos | 3 |
Medicines | 3 |
MDR | 3 |
Meng | 3 |
Methods | 3 |
MiP | 3 |
Mitchell | 3 |
Mol | 3 |
Morocco | 3 |
Mother | 3 |
Mulder | 3 |
Multicollinearity | 3 |
MyD88 | 3 |
Myanmar | 3 |
Edward | 3 |
MEDLINE | 3 |
MC(t | 3 |
Israel | 3 |
KS | 3 |
Istanbul | 3 |
Ivermectin | 3 |
Izmir | 3 |
JAK3 | 3 |
JIA | 3 |
Jia | 3 |
Journal | 3 |
Julio | 3 |
Jun | 3 |
Jäkel | 3 |
K | 3 |
K86Vfs118 | 3 |
Kaufmann | 3 |
MBL | 3 |
Kleinnijenhuis | 3 |
Krebs | 3 |
Kupffer | 3 |
LFP20 | 3 |
LTB | 3 |
LTZ | 3 |
Linial | 3 |
Lipopolysaccharide | 3 |
Liu | 3 |
Ln | 3 |
Local | 3 |
MAP | 3 |
Emergence | 3 |
Brucella | 3 |
Ecuador | 3 |
BTK | 3 |
Appelmelk | 3 |
Arabia | 3 |
Article | 3 |
Associations | 3 |
Attribution | 3 |
Autophagy | 3 |
Average | 3 |
B.C.G. | 3 |
B19 | 3 |
BD | 3 |
BM | 3 |
BMC | 3 |
Belarus | 3 |
Animal | 3 |
Bella | 3 |
Berg | 3 |
Bergh | 3 |
Bermudez | 3 |
Bigi | 3 |
Biovac | 3 |
Board | 3 |
Bratislava | 3 |
Broad | 3 |
NCF1 | 3 |
Budiawan | 3 |
Bulgaria | 3 |
Antibodies | 3 |
Al | 3 |
Burkholderia | 3 |
Ab | 3 |
19F | 3 |
3A | 3 |
A2a | 3 |
ABI | 3 |
ACE-2 | 3 |
ADA | 3 |
AFB | 3 |
AI | 3 |
AIHA | 3 |
AMP | 3 |
ASID | 3 |
ATM | 3 |
Abstract | 3 |
Ahmed | 3 |
Academy | 3 |
Accepted | 3 |
Accessed | 3 |
Activation | 3 |
Acute | 3 |
Adapazarı | 3 |
Adeeb | 3 |
Administration | 3 |
Advisory | 3 |
Aerosol | 3 |
Affairs | 3 |
Ag85B | 3 |
Bullous | 3 |
CCL2 | 3 |
EULAR | 3 |
Dengue | 3 |
Cpn60.2 | 3 |
Cryptococcus | 3 |
Cuba | 3 |
Cytomegalovirus | 3 |
César | 3 |
D. | 3 |
D100 | 3 |
DE1 | 3 |
DR+ | 3 |
DTP | 3 |
Day | 3 |
Delivery | 3 |
Dental | 3 |
Coronavirus-2 | 3 |
Deployment | 3 |
Diabetes | 3 |
Diagnostics | 3 |
Differential | 3 |
Director | 3 |
Domestic | 3 |
Drugs | 3 |
Dye | 3 |
Dysregulation | 3 |
E148Q | 3 |
EES | 3 |
EMEA | 3 |
Council | 3 |
Controlled | 3 |
CD1 | 3 |
CaCl | 3 |
CD11c | 3 |
CD18 | 3 |
CDC | 3 |
CH50 | 3 |
CMV | 3 |
COVID-19-attributable | 3 |
COVID-2019 | 3 |
CR3 | 3 |
CS3 | 3 |
CSF | 3 |
CTD | 3 |
CYBA | 3 |
California | 3 |
Consortium | 3 |
Cambridge | 3 |
Capozzo | 3 |
Carrero | 3 |
Case | 3 |
Cd19 | 3 |
Cells | 3 |
Chemiluminescence | 3 |
Cheng | 3 |
Chi | 3 |
Chitosan | 3 |
Column | 3 |
Comparison | 3 |
NBS1 | 3 |
Arnold | 3 |
NCT04348370 | 3 |
TX | 3 |
Xlinked | 3 |
Yang | 3 |
Zhou | 3 |
Zimbabwe | 3 |
antibiotherapy | 3 |
antigenspecific | 3 |
arteriosus | 3 |
arthralgia | 3 |
author(s | 3 |
b0 | 3 |
bcg | 3 |
biopsy | 3 |
brefeldin | 3 |
bronchoalveolar | 3 |
c. | 3 |
c.368 | 3 |
camostat | 3 |
chaperonin-1 | 3 |
cis | 3 |
citrate | 3 |
clarithromycin | 3 |
clinicaltrials.gov | 3 |
costimulatory | 3 |
crp | 3 |
cya | 3 |
dapsone | 3 |
del | 3 |
Wu | 3 |
Worldometer | 3 |
Workshop | 3 |
Türkiye | 3 |
Tailleux | 3 |
Tcell | 3 |
Tests | 3 |
Text | 3 |
Tf | 3 |
Th | 3 |
Tmax | 3 |
Town | 3 |
TrcR | 3 |
Tris | 3 |
Tuberculin | 3 |
Tween-20 | 3 |
UHC | 3 |
Working | 3 |
Universal | 3 |
Ural | 3 |
V | 3 |
V726A | 3 |
VII | 3 |
VN | 3 |
Vaccinology | 3 |
Validity | 3 |
Vector | 3 |
Verma | 3 |
Warburg | 3 |
Wellcome | 3 |
del1 | 3 |
dermatomyositis | 3 |
disease-2019 | 3 |
thymoma | 3 |
phoP. | 3 |
phthiocerol | 3 |
protein-1 | 3 |
rBCG30 | 3 |
range | 3 |
rev | 3 |
rheumatoid | 3 |
rifampicin | 3 |
sciences | 3 |
subgroups | 3 |
sunitinib | 3 |
therapy | 3 |
truncus | 3 |
pancytopenia | 3 |
tuberculoid | 3 |
zymosan | 3 |
ΓC | 3 |
γδ | 3 |
↓lung | 3 |
− | 3 |
−0.35 | 3 |
␣ | 3 |
 | 3 |
| 3 |
| 3 |
NCT04350931 | 3 |
perforin | 3 |
pan | 3 |
eBioscience | 3 |
interferon | 3 |
emetine | 3 |
encephalomyocarditis | 3 |
enterogenic | 3 |
flexneri | 3 |
fumarate | 3 |
gp160 | 3 |
herpesvirus-6 | 3 |
holo | 3 |
https://clinicaltrials.gov/. | 3 |
immunogens | 3 |
immunoglobuline | 3 |
influenza | 3 |
internalin | 3 |
palmoplantar | 3 |
international | 3 |
leukocytosis | 3 |
lipoarabinomannan | 3 |
lopinavir | 3 |
lprG. | 3 |
lung | 3 |
meningitidis | 3 |
mouse | 3 |
nef | 3 |
nir | 3 |
nonmuscle | 3 |
pag | 3 |
Taal | 3 |
epithelioid | 3 |
TLR2/6 | 3 |
Pam3Cys | 3 |
PDIM | 3 |
PFKP | 3 |
PFT | 3 |
PGR | 3 |
PKC | 3 |
PLS | 3 |
PMA | 3 |
PPV23 | 3 |
PRR | 3 |
PT3 | 3 |
PT4 | 3 |
Palmieri | 3 |
Parker | 3 |
PCV13 | 3 |
Pará | 3 |
Pathway | 3 |
Patients | 3 |
Period | 3 |
Philippines | 3 |
Pilot | 3 |
Pitarque | 3 |
PlcB | 3 |
Pneumococcal | 3 |
Polio | 3 |
Prism | 3 |
Product | 3 |
PCV7 | 3 |
PBMC | 3 |
Prophylaxis | 3 |
News | 3 |
NCT04414267 | 3 |
TH2 | 3 |
NCT04417335 | 3 |
NCTC | 3 |
NHS | 3 |
NaCl | 3 |
Nairobi | 3 |
Narcolepsy | 3 |
NaserEddin | 3 |
Nat | 3 |
Neutrophil | 3 |
Newcastle | 3 |
Nicotiana | 3 |
P=1×10 | 3 |
November | 3 |
Number | 3 |
OD | 3 |
OK | 3 |
OM-85 | 3 |
OP | 3 |
ORF | 3 |
ORF8 | 3 |
Old | 3 |
Ontario | 3 |
Open | 3 |
P2 | 3 |
Properties | 3 |
PAN | 3 |
Protease | 3 |
STm | 3 |
Saal | 3 |
Sakarya | 3 |
Sansonetti | 3 |
Saudi | 3 |
Sauton | 3 |
Saúde | 3 |
Shadur | 3 |
Shenzhen | 3 |
Societies | 3 |
SopE | 3 |
Southern | 3 |
Specific | 3 |
StataCorp | 3 |
Stem | 3 |
Stocker | 3 |
Stop | 3 |
Strain | 3 |
Student | 3 |
Subsequent | 3 |
Supplemental | 3 |
Survey | 3 |
Swedish | 3 |
Syncytial | 3 |
T1 | 3 |
QBC | 3 |
T385 | 3 |
TC | 3 |
SURTIME | 3 |
Spike | 3 |
SPSS | 3 |
Reviews | 3 |
Quebec | 3 |
RD1 | 3 |
ROS | 3 |
RSV | 3 |
Rapid | 3 |
RdRP | 3 |
QS | 3 |
Reducing | 3 |
Region | 3 |
Regulatory | 3 |
Responses | 3 |
Revaccination | 3 |
RdRp | 3 |
SArS | 3 |
S6 | 3 |
SOLIDARITY | 3 |
Rituximab | 3 |
SIMCOLEP | 3 |
SARS‐CoV‐2 | 3 |
SPI-2 | 3 |
S5 | 3 |
Ryan | 3 |
Rubella | 3 |
Royal | 3 |
Roberts | 3 |
Haveli | 2 |
HSM | 2 |
Hajjo | 2 |
Hamdard | 2 |
Hank | 2 |
Hart | 2 |
Hly | 2 |
Helsinki | 2 |
HbOC | 2 |
HeJ | 2 |
Hebrew | 2 |
Hegarty | 2 |
Hematoxylin | 2 |
Herrmann | 2 |
HIVBr18 | 2 |
H3K9 | 2 |
HIC | 2 |
HER2 | 2 |
HDAC | 2 |
HCl | 2 |
HCW | 2 |
HBSS | 2 |
HAV | 2 |
HALE | 2 |
H7 | 2 |
H4 | 2 |
Guillain | 2 |
Guèrin | 2 |
Gulhane | 2 |
Guérin | 2 |
Homozygous | 2 |
Hohmann | 2 |
IVIg | 2 |
HpaA | 2 |
IL-6R | 2 |
IgGRT | 2 |
Gu'erin | 2 |
IgG3 | 2 |
IgG2a | 2 |
Iceland | 2 |
IVS3 | 2 |
ISPID | 2 |
ISG | 2 |
IMDC | 2 |
IM | 2 |
IL8 | 2 |
IL1β | 2 |
IL12RB | 2 |
IL-7 | 2 |
IL-23 | 2 |
Hsp | 2 |
IL-15 | 2 |
IL | 2 |
IFNgamma | 2 |
IDH | 2 |
ID83 | 2 |
ID | 2 |
ICOS | 2 |
ICGEB | 2 |
IBM | 2 |
Hussain | 2 |
Humarán | 2 |
Humanitarian | 2 |
Huang | 2 |
HspX | 2 |
Guangdong | 2 |
Erc | 2 |
Grode | 2 |
F1 | 2 |
Features | 2 |
FcgammaRII | 2 |
Fc | 2 |
Favipiravir | 2 |
Father | 2 |
Fatality | 2 |
Fairbanks | 2 |
FWPV | 2 |
FTT | 2 |
FQHC | 2 |
FH | 2 |
FDI | 2 |
FADH2 | 2 |
FACS | 2 |
Experimental | 2 |
Fever | 2 |
Exchange | 2 |
EuroMOMO | 2 |
Etiopathogenesis | 2 |
Ethiopia | 2 |
Esat-6 | 2 |
Erasmus | 2 |
Epidemiological | 2 |
Epidemiol | 2 |
EpiEstim | 2 |
Enzyme | 2 |
Environmental | 2 |
Environment | 2 |
Environ | 2 |
Illness | 2 |
Fernandez | 2 |
Fidel | 2 |
Gringhuis | 2 |
Galdon | 2 |
Grande | 2 |
Gram | 2 |
Glutaminolysis | 2 |
Globe | 2 |
Glasser | 2 |
Giorgi | 2 |
Gil | 2 |
Giant | 2 |
Genome | 2 |
Generation | 2 |
Gaussians | 2 |
Gate | 2 |
Garza | 2 |
Gardasil | 2 |
Gadepalli | 2 |
Free | 2 |
GST | 2 |
GSE58636 | 2 |
GPZL | 2 |
GO | 2 |
GM | 2 |
GISAID | 2 |
GEO | 2 |
G251V | 2 |
G1124V | 2 |
Functional | 2 |
Function | 2 |
Friends | 2 |
Friedman | 2 |
French | 2 |
Igwe | 2 |
Mass | 2 |
Immunodeficiencis | 2 |
Luxembourg | 2 |
Ljubljana | 2 |
Low | 2 |
Luc | 2 |
Lumpur | 2 |
Lundqvist | 2 |
Lung | 2 |
Lwin | 2 |
Immunoglobuline | 2 |
Lyophilized | 2 |
MAC | 2 |
MAC219 | 2 |
MBP | 2 |
MBT | 2 |
MINT | 2 |
Lithuanian | 2 |
Lithuania | 2 |
Listerial | 2 |
Light | 2 |
Libya | 2 |
Lfcin | 2 |
Levene | 2 |
Leukocyte | 2 |
Leuk | 2 |
Leucocyte | 2 |
Leishmaniasis | 2 |
Leipzig | 2 |
Legionella | 2 |
Laura | 2 |
Lau | 2 |
Latent | 2 |
Lassa | 2 |
MIP | 2 |
MPT51 | 2 |
MR | 2 |
Matrix | 2 |
Mercury | 2 |
Mercatelli | 2 |
Mendelian | 2 |
Memorial | 2 |
Meier | 2 |
Mei | 2 |
Mehra | 2 |
Meer | 2 |
Mediterranean | 2 |
McMichael | 2 |
McLaughlin | 2 |
Małgorzata | 2 |
Mayıs | 2 |
Mayo | 2 |
Mathematical | 2 |
MST-312 | 2 |
Embase | 2 |
Masayuki | 2 |
Marshall | 2 |
Marc | 2 |
Manchester | 2 |
ManLAM | 2 |
Mali | 2 |
Madagascar | 2 |
Macrophagic | 2 |
MacDonald | 2 |
Mac | 2 |
MVAC | 2 |
MV | 2 |
MSgpM | 2 |
Language | 2 |
Langerhans | 2 |
Lactoferricin | 2 |
Irina | 2 |
Joint | 2 |
JohannesHaushofer | 2 |
Job | 2 |
Jiang | 2 |
Jerker | 2 |
Jennison | 2 |
Jan | 2 |
Jamia | 2 |
JC | 2 |
JAMA | 2 |
Ivanyi | 2 |
Items | 2 |
Isfahan | 2 |
Iron | 2 |
Investment | 2 |
Jordan | 2 |
Intracellular | 2 |
Interquartile | 2 |
Interim | 2 |
Interest | 2 |
Intensive | 2 |
Instruments | 2 |
Inheritance | 2 |
Infolep | 2 |
Influence | 2 |
Inflammasome | 2 |
Indicators | 2 |
Increased | 2 |
Immunosuppression | 2 |
Immunomodulatory | 2 |
Jonsson | 2 |
Jose | 2 |
LacI | 2 |
Kuala | 2 |
LYH | 2 |
LV | 2 |
LT | 2 |
LS | 2 |
LRI | 2 |
LMIC | 2 |
LLC | 2 |
LFP-20 | 2 |
LF33 | 2 |
LCR22-A | 2 |
L37F | 2 |
L1000 | 2 |
Kyle | 2 |
Kutukculer | 2 |
Kotb | 2 |
José | 2 |
Koplik | 2 |
Koch | 2 |
Kleen | 2 |
Klebsiella | 2 |
Klaus | 2 |
Klaassen | 2 |
Kitti | 2 |
King | 2 |
Kinetics | 2 |
Killer | 2 |
Kermack | 2 |
Kartal | 2 |
Kaplan | 2 |
KEGG | 2 |
Energy | 2 |
COviD-19 | 2 |
Eluted | 2 |
Averbuch | 2 |
Barillas | 2 |
Bare | 2 |
Bacterial | 2 |
Background | 2 |
BZ | 2 |
BNT162b1 | 2 |
BCR | 2 |
BCAN | 2 |
BBB | 2 |
BAD | 2 |
BACKGROUND | 2 |
Aziz | 2 |
Award | 2 |
Avraham | 2 |
Autoimmunity | 2 |
Ben | 2 |
Austria | 2 |
Atomic | 2 |
AstraZeneca | 2 |
Asterisk | 2 |
Aspergillus | 2 |
Ashish | 2 |
Asd | 2 |
Arts | 2 |
Arthritis | 2 |
Artemis | 2 |
AraC | 2 |
Applied | 2 |
Applications | 2 |
Antiviral | 2 |
Beckman | 2 |
Benn | 2 |
Antibiotics | 2 |
Brazilian | 2 |
CD1-restricted | 2 |
CCR7 | 2 |
CCR5 | 2 |
CBA | 2 |
CASE | 2 |
CAPE | 2 |
C57BL/6 | 2 |
C18 | 2 |
C10 | 2 |
Butt | 2 |
Burma | 2 |
Bumann | 2 |
Btk | 2 |
Brief | 2 |
Braza | 2 |
Berinert | 2 |
Branch | 2 |
Bozdoğan | 2 |
Bonten | 2 |
Blue | 2 |
Biosystems | 2 |
Biomed | 2 |
Biology | 2 |
Biologics | 2 |
Bioinformatics | 2 |
Biochemistry | 2 |
Bioactive | 2 |
Bifidobacterium | 2 |
Betacoronavirus | 2 |
Bermúdez | 2 |
Antigens | 2 |
Anita | 2 |
CD16 | 2 |
A(H1N1 | 2 |
ASD | 2 |
APN01 | 2 |
AP2 | 2 |
AP-1 | 2 |
AOR | 2 |
ANCA | 2 |
AMPK | 2 |
ALF | 2 |
AKT | 2 |
AFDA | 2 |
AF2122/97 | 2 |
AB | 2 |
A22 | 2 |
A117 | 2 |
<3 | 2 |
AST | 2 |
72F | 2 |
5c | 2 |
500mg | 2 |
500FG | 2 |
400mg | 2 |
300BCG | 2 |
2V | 2 |
2GPI | 2 |
18C | 2 |
0.5 | 2 |
-Tice | 2 |
-Sigma | 2 |
-40 | 2 |
Method | 2 |
ASO3-adjuvanted | 2 |
ATF3 | 2 |
Angelakopoulos | 2 |
Alexander | 2 |
Andrea | 2 |
Analyses | 2 |
Amuguni | 2 |
Amsterdam | 2 |
Amphotericine | 2 |
Amersham | 2 |
Americas | 2 |
Americans | 2 |
Amazonas | 2 |
Aluminum | 2 |
Alum | 2 |
Alternative | 2 |
Allergology | 2 |
Algeria | 2 |
Albert | 2 |
AUA | 2 |
Aksu | 2 |
Aim | 2 |
Advice | 2 |
Additional | 2 |
Ad5-nCoV | 2 |
Ad5 | 2 |
Activity | 2 |
ActA | 2 |
Act | 2 |
Acre | 2 |
Access | 2 |
Acceptability | 2 |
Abs | 2 |
Abinun | 2 |
CD141 | 2 |
CD20 | 2 |
Elpeleg | 2 |
DHR | 2 |
Diana | 2 |
DiNardo | 2 |
Demographic | 2 |
Defense | 2 |
Declaration | 2 |
Davis | 2 |
Dalgleish | 2 |
Dadra | 2 |
DUSP | 2 |
DORV | 2 |
DOCK8 | 2 |
DNase | 2 |
DLI | 2 |
DIP | 2 |
DFS | 2 |
Dinur | 2 |
DENV | 2 |
DCSIGN | 2 |
DC(t | 2 |
DBD | 2 |
DAP | 2 |
DADDS | 2 |
Czechoslovakia | 2 |
Cutibacterium | 2 |
Curtiss | 2 |
Cryptosporidium | 2 |
Croatia | 2 |
Coxsackievirus | 2 |
Coxiella | 2 |
Covid19 | 2 |
Ding | 2 |
Dipeptide | 2 |
Could | 2 |
ERA | 2 |
Ellen | 2 |
Elimination | 2 |
El | 2 |
Ehud | 2 |
Ege | 2 |
Effects | 2 |
Edanz | 2 |
EcoCyc | 2 |
Early | 2 |
EVIDENCE | 2 |
EUA | 2 |
EU | 2 |
ETEC | 2 |
ESX-2 | 2 |
EORTC | 2 |
Direct | 2 |
EOC | 2 |
EMC | 2 |
ECDC | 2 |
ECAR | 2 |
EC50 | 2 |
EAE | 2 |
E7 | 2 |
E2 | 2 |
Duration | 2 |
Dunstan | 2 |
Dolgikh | 2 |
Dniepropetrovsk | 2 |
DnaJ | 2 |
Discovery | 2 |
Coulter | 2 |
Coronaviruses | 2 |
CD209 | 2 |
COVID19 | 2 |
Centers | 2 |
Cases | 2 |
Carroll | 2 |
Candidiasis | 2 |
Canadian | 2 |
Camille | 2 |
Cairo | 2 |
Caco-2 | 2 |
CYP3A4 | 2 |
CYP2C8 | 2 |
CSR | 2 |
CRP | 2 |
CRISPR | 2 |
CPH | 2 |
COVID-19-specific | 2 |
Chandigarh | 2 |
COVD-19 | 2 |
CMCD | 2 |
CLEC7A | 2 |
CIS | 2 |
CHO | 2 |
CFR1000 | 2 |
CFP10 | 2 |
CD81 | 2 |
CD8+CD38hiPD-1 | 2 |
CD68 | 2 |
CD57 | 2 |
CD45RO | 2 |
CD44 | 2 |
CD22 | 2 |
Cervarix | 2 |
Characterization | 2 |
Corona | 2 |
Collection | 2 |
Cori | 2 |
Cooke | 2 |
Conventional | 2 |
Contribution | 2 |
Contact | 2 |
Connectivity | 2 |
Congo | 2 |
Conferences | 2 |
Concentrations | 2 |
Complex | 2 |
Comoros | 2 |
Community | 2 |
Commission | 2 |
Colombia | 2 |
Collaborative | 2 |
Charles | 2 |
Coinfection | 2 |
Cohort | 2 |
Coast | 2 |
CoV-2-specific | 2 |
Clonorchis | 2 |
Clock | 2 |
Chromatin | 2 |
Christ | 2 |
Childhood | 2 |
Child | 2 |
Chief | 2 |
Chelyabinsk | 2 |
Chauchet | 2 |
Charvet | 2 |
Merle | 2 |
Eq | 2 |
Methylprednisolone | 2 |
cytopenia | 2 |
chaperonin | 2 |
chemocentric | 2 |
colchicine | 2 |
committee | 2 |
cruzi | 2 |
cytomegalovirus | 2 |
d. | 2 |
Toxoplasma | 2 |
data | 2 |
death-1 | 2 |
dehydrogenase | 2 |
delta | 2 |
deoxyguanosine | 2 |
development | 2 |
canarypox | 2 |
cDNA | 2 |
cCFR100 | 2 |
bw | 2 |
busulphan | 2 |
bronchiolitis | 2 |
bovis | 2 |
blau | 2 |
bifidobacteria | 2 |
benthamiana | 2 |
bLF | 2 |
b1**t | 2 |
b1 | 2 |
autotransporter | 2 |
autoinflammatory | 2 |
autoantibody | 2 |
aspergillosis | 2 |
dinucleotide | 2 |
docetaxel | 2 |
dpm | 2 |
gp41 | 2 |
immunoregulatory | 2 |
immunoassays | 2 |
i.p | 2 |
hyperkeratosis | 2 |
hyperbilirubinemia | 2 |
https://www.cato.org/sites/cato.org/files/human-freedom-index-files/human-freedom-index-2018-revised.pdf | 2 |
https://github.com/nadavrap/COVID19 | 2 |
https://en-author-services.edanzgroup.com/ac | 2 |
https://doi.org/10.1101/2020.09.09.20191684 | 2 |
https://doi.org/10.1101/2020.06.03.20121624 | 2 |
https | 2 |
health | 2 |
guinea | 2 |
guaBA | 2 |
gp140 | 2 |
e**(b0 | 2 |
gm | 2 |
glycolipid | 2 |
glyceraldehyde-3 | 2 |
glutaminolysis | 2 |
gammadelta | 2 |
g. | 2 |
fever | 2 |
ferroportin | 2 |
fadD26 | 2 |
exones | 2 |
escherichia | 2 |
enterohemorrhagic | 2 |
endosomal | 2 |
endophthalmitis | 2 |
aroA | 2 |
analysis | 2 |
alopecia | 2 |
Uruguay | 2 |
Vδ2 | 2 |
Vivo | 2 |
Vigilância | 2 |
Vero | 2 |
Vergkizi | 2 |
Ventura | 2 |
Vaxgen | 2 |
Valk | 2 |
Vaccinated | 2 |
VP7 | 2 |
VLP | 2 |
VIFs | 2 |
VEGF | 2 |
VAERS | 2 |
Urol | 2 |
WHIM | 2 |
Updates | 2 |
Umifenovir | 2 |
UMIC | 2 |
UC(t | 2 |
Tzipori | 2 |
Tyr238X | 2 |
Tyne | 2 |
Turkiye | 2 |
Ts87 | 2 |
Trust | 2 |
Tropsha | 2 |
Triton | 2 |
Translational | 2 |
Transfection | 2 |
WES | 2 |
Wales | 2 |
alanine | 2 |
Yan | 2 |
airways | 2 |
ageusia | 2 |
africa | 2 |
acetyl | 2 |
Zoster | 2 |
Zika | 2 |
Zeev | 2 |
Zaidman | 2 |
Zagazig | 2 |
Zachary | 2 |
Z | 2 |
Yvan | 2 |
Yuval | 2 |
Yu | 2 |
Yael | 2 |
Wallis | 2 |
YN907 | 2 |
YFV | 2 |
YF | 2 |
Y. | 2 |
XLP | 2 |
XL | 2 |
Windows | 2 |
Wendeln | 2 |
Web | 2 |
Wayne | 2 |
Washington | 2 |
Warsaw | 2 |
Warnatz | 2 |
Warnakulasuriya | 2 |
informatics | 2 |
inlB | 2 |
interleukin-10 | 2 |
syndrome | 2 |
uro | 2 |
urease | 2 |
typhi | 2 |
trombocytopenia | 2 |
tricarboxylic | 2 |
transmembrane | 2 |
trans | 2 |
tolerogenic | 2 |
th17 | 2 |
th1 | 2 |
tetrasolium | 2 |
telangiectasia | 2 |
tachypnea | 2 |
tC | 2 |
subindex | 2 |
workflow | 2 |
ssa | 2 |
spp | 2 |
specific | 2 |
south | 2 |
serogroup | 2 |
series | 2 |
sativum | 2 |
sarilumab | 2 |
sIgAD | 2 |
s1 | 2 |
route | 2 |
rho | 2 |
rheumatica | 2 |
review)The | 2 |
varicellae | 2 |
www.ESID.org | 2 |
reF. | 2 |
↓inflammation | 2 |
10 | 2 |
Michael | 2 |
C | 2 |
≥70 | 2 |
≥60 | 2 |
≥15 | 2 |
≤20/1,000,000 | 2 |
−0.58 | 2 |
−0.54 | 2 |
−0.48 | 2 |
−0.47 | 2 |
−0.32 | 2 |
−0.14 | 2 |
↔IFNγ | 2 |
↓IL-1β | 2 |
xxx | 2 |
↑IFNγ | 2 |
‡ | 2 |
ρ=0.54 | 2 |
μS | 2 |
γBCG | 2 |
Özdemir | 2 |
Östling | 2 |
Öner | 2 |
À20 | 2 |
® | 2 |
© | 2 |
zoster | 2 |
y.o | 2 |
xxxx | 2 |
receptor-1 | 2 |
raltegravir | 2 |
intra | 2 |
marinum | 2 |
multicentre | 2 |
mucosal | 2 |
mitogens | 2 |
mitogen | 2 |
mit | 2 |
middle | 2 |
microRNAs | 2 |
miR-27b | 2 |
mg*2 | 2 |
methotrexate | 2 |
metabolome | 2 |
mesylate | 2 |
meningococcus | 2 |
measles | 2 |
mansoni | 2 |
mutation(s | 2 |
mL. | 2 |
lysin | 2 |
lymphocytopenia | 2 |
lo | 2 |
ligand-1 | 2 |
leukocytoclastic | 2 |
lamblia | 2 |
lactoferrampin | 2 |
km | 2 |
kb | 2 |
jejuni | 2 |
ivermectin | 2 |
irr | 2 |
intracellulare | 2 |
muramyldipeptide | 2 |
mycobacterium | 2 |
pylori | 2 |
pemphigus | 2 |
ptbnet | 2 |
provirus | 2 |
propria | 2 |
pro | 2 |
pristane | 2 |
postchemotherapy | 2 |
posaconazole | 2 |
polymyalgia | 2 |
polyangiitis | 2 |
phospho | 2 |
phorbol | 2 |
phoR | 2 |
phagocyte | 2 |
pestis | 2 |
paraformaldehyde | 2 |
myelocytes | 2 |
para | 2 |
pLf | 2 |
p=0.049 | 2 |
owner(s | 2 |
ovalbumin | 2 |
obuense | 2 |
obliterans | 2 |
nucleoprotein | 2 |
nonintegrin | 2 |
nodosa | 2 |
nitro | 2 |
neu | 2 |
nCoV-19 | 2 |
nC(t | 2 |
Transcriptional | 2 |
immunomodulator | 2 |
Tocilizumab | 2 |
Paediatric | 2 |
PNO | 2 |
PO | 2 |
PT15 | 2 |
PT5 | 2 |
Pac | 2 |
Pacific | 2 |
Panel | 2 |
RAVES | 2 |
Papillomavirus | 2 |
Papua | 2 |
Para | 2 |
Paradigm | 2 |
Parvovirus | 2 |
Pathogenesis | 2 |
PLT | 2 |
PIII | 2 |
PGED | 2 |